Mural Oncology Presents Clinical and Preclinical Data Across its Pipeline at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
Less frequent IV dosing with nemvaleukin in patients with select advanced solid tumors, including ovarian cancer and mucosal melanoma, showed ...
Business Insider1d
MiNK Therapeutics presents data on iNKT cell therapy programs
MiNK Therapeutics (INKT) announced data from two poster presentations at the Society for Immunotherapy of Cancer’s 39th Annual Meeting in Houston, Texas. The presentations showcased new data from MiNK ...